APA / OTS

IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY).

Due to the corona pandemic, general practitioners and specialists face the challenge of maintaining their practice without putting patients and staff at increased risk of infection. In Hamburg, Germany, another medical practice has implemented health protection measures using DERMALOG's non-contact fever detection.

International Osteoporosis Foundation Announces First-of-its-Kind Partnership With University of Oxford, Amgen and UCB to Combat Global Public Health Burden of Osteoporosis [1] Hip and Vertebral Fractures are Costly for Society and Can be Life-Altering for Patients [2], [3]

Due to the corona pandemic, hospitals and clinics face the challenge of maintaining practice without putting patients and staff at increased risk of infection. Greifswald University Hospital in Germany has implemented health protection measures using DERMALOG's non-contact fever detection.

After a mandatory corona break of several weeks, social services such as day and advice centers for homeless people are reopening in Germany. Operators have to comply with numerous hygiene regulations to minimize infection risks for customers and employees. This is why the MAhL ZEIT homeless day center has opted for DERMALOG's non-contact fever detection.